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Abstract: Participant adherence to standardized 8-week mindfulness-based interventions (MBIs) may be
challenging, and adaptations from intervention protocols have been reported in mindfulness research.
We conducted a scoping review to determine how women with breast or gynecological cancer adhered
to standardized 8-week MBIs delivered in intervention studies. Searches were conducted for articles
published till February 2020 in PubMed, Embase, CINAHL EBSCO, PsycINFO Ovid SP, and Cochrane
Library Wiley. The following outcomes were investigated: class and silent retreat attendance, intervention
completion rate (ICR), adherence to home practice, and reasons for dropping out from an MBI study.
Among the 25 included MBI studies, mindfulness-based stress reduction was the most often delivered
intervention and mostly women with stage I–III breast cancer were represented. The duration of classes
varied from 1.5 to 3.5 hours. Planned home practice varied from 20 to 60 min/day, and silent retreat
varied from 4.5 to 8 hours. Due to heterogeneity in the reporting of class attendance, the data could
not be pooled. Six studies reported an average class attendance ranging from 5 to 8.2 classes. Overall,
intervention completion rate (the proportion who completed all classes) varied from 26.3% to 100%;
however, discontinuations were not systematically reported. Home practice time was reported in 20% of
the studies and ranged from 17 to 24 min/day. The main reasons for dropping out from an MBI study were
health-related problems, organizational challenges, travel distance, and lack of motivation/commitment.
About 70% of the studies reported some data on participant adherence, revealing a relatively high overall
frequency of class attendance. However, the monitoring and reporting of participant adherence should be
improved in future studies to increase our knowledge on the required amount of participant engagement
to improve health outcomes and facilitate the implementation of effective interventions on a larger scale.
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Abstract
Participant adherence to standardized 8-week mindfulness-based interventions (MBIs) may be challenging, and adaptations from
intervention protocols have been reported in mindfulness research. We conducted a scoping review to determine how women with
breast or gynecological cancer adhered to standardized 8-weekMBIs delivered in intervention studies. Searches were conducted for
articles published till February 2020 in PubMed, Embase, CINAHL EBSCO, PsycINFO Ovid SP, and Cochrane Library Wiley. The
following outcomes were investigated: class and silent retreat attendance, intervention completion rate (ICR), adherence to home
practice, and reasons for dropping out from an MBI study. Among the 25 included MBI studies, mindfulness-based stress reduction
was the most often delivered intervention and mostly women with stage I–III breast cancer were represented. The duration of classes
varied from 1.5 to 3.5hours. Planned home practice varied from 20 to 60min/day, and silent retreat varied from 4.5 to 8hours. Due to
heterogeneity in the reporting of class attendance, the data could not be pooled. Six studies reported an average class attendance
ranging from 5 to 8.2 classes. Overall, intervention completion rate (the proportion who completed all classes) varied from 26.3% to
100%; however, discontinuations were not systematically reported. Home practice time was reported in 20% of the studies and
ranged from 17 to 24min/day. The main reasons for dropping out from an MBI study were health-related problems, organizational
challenges, travel distance, and lack of motivation/commitment. About 70% of the studies reported some data on participant
adherence, revealing a relatively high overall frequency of class attendance. However, the monitoring and reporting of participant
adherence should be improved in future studies to increase our knowledge on the required amount of participant engagement to
improve health outcomes and facilitate the implementation of effective interventions on a larger scale.
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1. Introduction
About 35% of patients with cancer use complementary treat-
ments in the United States.[1] Patient-centered integrative
medicine refers to combining conventional medicine and
evidence-based complementary treatments.[2] Globally, comple-
mentary treatments include biological (eg, phytomedicine, diet)
as well as mind-body interventions (eg, hypnosis, acupuncture,
and meditation including mindfulness-based stress reduction
[MBSR]).[2] Mindfulness-based interventions (MBIs) are ground-
ed inmindfulness meditation, defined as a deliberate awareness of
the present experience in a non-judgmental attitude.[3] Stan-
dardized MBIs like MBSR[4] or mindfulness-based cognitive
therapy (MBCT)[5] consist of 8 weekly in-group classes (up to 3.5
hour/class) with an additional silent retreat (up to 7.5hours)
delivered during this 8-week period. The classes include body
scan, sitting meditation, gentle yoga, mindful walking, group
discussions, and psychoeducation. Between weekly classes, home
practice is required with 45min/day of formal practice (with pre-
recorded guided meditations), and 15min/day of informal
practice.
Standardized MBSR or MBCT is effective for mental health
outcomes (mainly anxiety and depression) in oncology.[6,7]
Although most MBIs studies include women with breast cancer,
results cannot yet be generalized to other gynecological cancers,
less represented in published studies to date. In addition,
participant adherence (eg, attendance to classes) to all compo-
nents of MBIs may be challenging, and reduced versions have
been adapted (eg, 1.5hour classes or 4–6 classes).[8] Small but
significant associations were reported between a higher adher-
ence to home practice of MBSR or MBCT and better clinical
outcomes like psychological functioning (eg, anxiety).[9,10]
Recently, a dose–response analysis (prediction of specific
outcomes in relation to the amount of use of an intervention)
including 203 randomized controlled trials (RCTs) of MBIs (≥1
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class) reported that mindfulness (as an outcome) was also
impacted by the dose of the intervention (face-to-face contact;
program intensity and use).[11] In contrast, in the same study, no
evidence for dose–response relationships was found for psycho-
logical outcomes like depression or anxiety.[11] Experts present
controversial opinions about the expected length of formal
practice, and the minimal dose of MBIs needed to impact
outcomes in a clinically meaningful way is still unclear.[8]Overall,
literature shows that participant adherence in MBIs studies could
be better described.[9,12]
Reporting guidelines for nonpharmacological interventions
recommend to describe how interventions are delivered (ie, their
dosage), including the degree of participant adherence to those
plans.[13] This information might promote stronger conclusions
on dose-related effects,[14,15] and increase the robustness of the
analysis of the MBIs being tested.[16] In addition, systematic
information on participants’ degree of adherence to the
prescribed dosage will promote evidence-based implementation
strategies. In this perspective, we conducted a scoping reviewwith
an overall aim of determining the adherence of women with
breast or gynecological cancer to standardized 8-week MBIs
delivered in intervention studies. The specific objectives were to:
1. Describe participants class and silent retreat attendance,
intervention completion rate (ICR), and adherence to home
practice within MBI studies.
2. Describe the reasons for dropping out from an MBI study.
2. Methods
2.1. Inclusion and exclusion criteria
This review included intervention studies involving adult women
with breast or gynecological cancer independent of the disease
stage. The inclusion criteria were: standardized group face-to-
face 8-weekMBIs; studies with less intense interventions in terms
of duration of the classes, silent retreat, and assigned home
practice; and intervention studies, that is, RCTs, quasi-experi-
ments, and pre-post studies. Publications were included in any
language that could be understood by the study team (English,
French, German, or Italian). Articles with mixed cancer
populations (other than breast and gynecological), articles
involving interventions with mindfulness as a minor part of
the treatment, conference abstracts, reviews, opinion papers,
editorials, and comments on original articles were excluded. The
outcomes of interest were: the class and silent retreat attendance,
ICR, adherence to home practice, and reasons for dropping out
from an MBI study.
2.2. Search strategy and data selection
Articles were searched following a 2-step approach. In step 1, a
librarian performed a first search until November 2018 (no
limitation in the timeframe) on PubMed, Embase, CINAHL
EBSCO, PsycINFO Ovid SP, and Cochrane Library Wiley. The
PRISMA guideline for systematic reviews was followed. In step 2,
an update of the literature was performed in February 2020 by the
first author with the same methodology. No filters were applied.




on outcomes were not included in search strategy. Search strategy
is presented in the supplemental digital content (SDC) Table 1,
http://links.lww.com/OR9/A25. The first author screened titles,
abstracts, and relevant full texts. Overlapping results from same
samples were excluded during full text review.
2.3. Data extraction
The first and third authors performed the data extraction
independently. Discrepancies were discussed, and the last author
was solicited in case of disagreements.
Attendance referred to the number of women who participated
in classes or in silent retreat. Where possible we calculated the
ICR (as the proportion of women who completed all classes)[17]
applying the following formula (higher rates indicate a higher
proportion of participants who completed all the 8 classes):
ICR ð%Þ ¼
numberwho completed interventionX 100
number assigned to intervention group
Adherence to home practice was defined as the amount of home
practice completed daily (in minutes per day). Participants who
dropped out from an MBI study referred to women who were
assigned to the mindfulness group but did not complete the study.
The reasons for study dropouts for control groups are
accessible in SDC, Table 2, http://links.lww.com/OR9/A25.
Additional data on study participation (number assessed for
eligibility, number eligible, number ineligible and reasons for
ineligibility, reasons for refusing to take part in an MBI study,
study participation rates, and study completion rates) are
available in SDC, Table 3, http://links.lww.com/OR9/A25.
3. Results
A total of 1164 articles were screened based on their titles and
abstracts. After full-text examination, 26 articles were included in
the scoping review, referring to 25 intervention studies since 1
study was reported in 2 articles. All included publications were in
English. Themain reasons for exclusionwere related to designs or
interventions that did not fit our inclusion criteria (Fig. 1).
The included studies were published between 2004 and
February 2020. Majority were conducted in western countries,
mainly the United States, Canada (n=11), and European
countries (n=6). Non-RCT studies were predominant (n=14).
Five studies[18–22] included active control groups. Majority of the
studies included women with breast cancer.[18–41] Four stud-
ies[19,24,32,40] included all stages of breast cancer, withmajority of
the patients being stage 0–III. Four studies[20,29,39,42] did not
report stages of cancer. Stafford et al[29] did a pre-post study and
included women (n=53) with breast (71%) or gynecological
cancer (29%). Zhang et al (2019)[42] included specifically women
with gynecological cancer (n=70) in their RCT. Chung et al[33]
(n=32) and Eyles et al[30] (n=20) focused specifically on women
with metastatic cancers.
Most of the tested interventions were MBSRs (n=17). The
weekly classes varied from 1.5 to 3.5hours, and 2 studies did not
report the duration of the classes provided.[21,26] Planned home
practice time ranged from 20 to 60 minutes, and 13 studies did
not report the duration of the planned home practice time.[18,21–
23,26,27,34,35,38–42] A silent retreat was delivered in 11 stud-
ies,[18,19,22–24,26,28,30,32,36,41] with a duration varying from 4.5 to
8hours. In 3 studies, a silent retreat was not delivered,[31,37] or a
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6-hour optional silent retreat was provided.[29] Twelve studies
gave unclear or no information about the delivery of a silent
retreat or its duration (Table 1).[20,21,25–27,33–35,38–40,42]
2.4. Participants adherence to mindfulness-based
interventions
Class attendance varied among the different studies. Due to
heterogeneity in the class attendance reporting, data could not be
pooled. Some authors reported the number of attenders for
groups of classes (categorization varying among stud-
ies),[19,22,23,25,28,29,30,33,37] whereas other authors reported the
mean number of classes attended.[24,26,28,30,31,37] Six studies did
not report any data on class attendance as well as ICR.[18,21,34,38–
40] Fixed cut-offs for ICR varied among studies: ≥6 classes
completed,[25,29,30] ≥5 classes completed,[28] or ≥4 classes
completed.[33] In 9 studies, it was unclear whether participants
completed the 8 classes or some participants discontinued (missed
≥1 class).[20,22,24,26,32,35,36,41,42] ICRs were reported in 3 studies;
Tacon et al (2011) reported a total number of participants (n=
65, women with breast cancer, stages I–II) completing all classes
(ICR=100%);[27]Carlson et al (2013) reported an ICR of 68.1%
(n=113, women with breast cancer, mainly stage 0–III)[19] and
Lengacher et al (2011) reported an ICR of 26.3% (n=19, women
with breast cancer, stage 0–III).[25] Overall, ICR varied from
26.3% to 100%; however, discontinuations were not systemati-
cally reported.
Completion of a silent retreat was reported in 5 stud-
ies.[19,23,24,26,30] The other studies were unclear or did not
report any data on silent retreat attendance. Adherence to home
practice was reported in 5 studies[25,26,28,31,43] and ranged from
17 to 24min/day (Table 2).
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Figure 1. Flow diagram of the study selection. From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for
Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097.
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2.5. Reasons for dropping out from an MBI study
The main reasons provided in the studies as reported by
participant who dropped out from an MBI study were: health-
related problems, organizational challenges, travel distance and
lack of motivation/commitment (Table 3). Eight studies did not
report or were unclear about the reasons for dropping out from
an MBI study.[18–21,36,39–41]
4. Discussion
This scoping review describes participants adherence to stan-
dardized 8-week MBIs delivered in intervention studies and the
main reasons for dropping out from an MBI study. Our review
revealed a relatively high overall adherence to MBIs by women
with breast or gynecological cancer. The mean class attendance
ranged from 5 to 8.2 classes, and the ICR varied between 26.3%
and 100%.Home practice ranged from 17 to 24min/day andwas
only reported for women with breast cancer.
More generally, Parsons et al (2017) reported a mean of 29
min/day of home practice (n=43 studies) for both the patients
and healthy participants[9] and represented 64%of the amount of
practice recommended in the manualized MBSR[4] and MBCT
programs.[5] These results are comparable to home practice
performed by women with breast cancer in our review. The main
reasons for dropping out from anMBI study were mostly health-
related problems, organizational challenges, travel distance, and
lack of motivation/commitment. This information suggests that
adaptations of the format might help to increase participant
adherence to MBIs. Format changes like online MBIs are
emerging in the context of cancer. An online version of the
MBCR was tested among highly distressed patients with any
stage of cancer. Results showed that 83.3% attended ≥5 classes.
Table 1



















Tacon et al[40] 2004 USA Breast, 0–IV
∗
, 27 (4) Pre-post MBSR 1.5 n/r n/r —
Tacon et al[39] 2006 USA Breast, n/r, 40 (n/r) Pre-post MBSR 1.5 n/r n/r —
Witek et al[23] 2008 USA Breast, 0–II, 75 () Quasi-experimental MBSR 2.5 n/r y; 8† Usual care
Matousek et al[24] 2010 Canada Breast, 0–IV, 62 (6) Pre-post MBSR 2.5 45–60 y; 6 —
Lengacher et al[25] 2011 USA Breast, 0–III‡, 19 () Pre-post MBSR (BC) 2 45 n/r —
Matchim et al[26] 2011 USA Breast, 0–II, 36 () Quasi-experimental MBSR n/r n/r y; n/r Usual care
Tacon et al[27] 2011 USA Breast, I–II, 65 () Pre-post MBSR 1.5 n/r n/r —
Henderson et al[18] 2012 USA Breast, I–II, 180 () RCT MBSR 2.5–3.5 n/r y; 7.5 – Nutrition educational
program
– Usual care












Endometrial, n/r, 53 (n/r)




Würtzen et al[41] 2013 Denmark Breast, I–III, 336 () RCT MBSR 2 n/r y; 5 Usual care
Eyles et al[30] 2015 England Breast, IV, 20 (20) Pre-post MBSR 2–2.5 30 y; 4.5 —
Johannsen et al[31] 2016 Denmark Breast, I–III, 129 () RCT MBCT 2 45 n Wait-list
Bisseling et al[32] 2017 Netherlands Breast, 0–IVjj, 64 (6) Pre-post MBSR 2.5 45 y; 6 —
Chung et al[33] 2017 Korea Breast, IV, 32 (32) Quasi-experimental MBSR¶ 2 54 n/r Wait-list
Kenne et al[20] 2017 Sweden Breast, n/r, 177 (n/r) RCT MBSR 2 20 n/r – Self-instructing MBSR (no
group)
– Usual care
Norouzi et al[34] 2017 Iran Breast, II, 24 () RCT MBCT 2.5 n/r n/r Usual care
Pintado et al[21] 2017 Mexico Breast, I–II, 29 () RCT MBCR n/r n/r n/r 5 Group sessions of
personal image advice
Vaziri et al[35] 2017 Iran Breast, I–III, 20 () Quasi-experimental MBCT 2 n/r n/r Wait-list
Zhang et al[36] 2017 China Breast, I–III, 60 () RCT MBSR (BC) 2 40–45 y; 8 Usual care
Park et al[37] 2018 Japan Breast, I–III, 13 () Pre-post MBCT 2 20–45 n —
Witek et al[22] 2019 USA Breast, 0–III, 192 () RCT MBSR 2.5 n/r y; 6 Cancer recovery and health
education
Zhang et al[42] 2019 China Cervical, n/r, 70 (n/r) RCT MBSR 2 n/r n/r Usual care
Elimimian et al[38] 2020 USA Breast, I–III, 94 () Pre-post MBSR 2 n/r n/r —
MBCT=mindfulness-based cognitive therapy, MBCR=mindfulness-based cancer recovery, MBSR=mindfulness-based stress reduction, MBSR (BC)=mindfulness-based stress reduction for breast cancer, n/
r=not reported, or unclear information (eg, dosage not reported, intervention described in the background, but not sure all components or dosage was planned to be the same).
∗
Inclusion of localized and metastatic cancers—unclear whether stage 0–IV or I–IV.
† Reported as a full-day retreat in the article—to our knowledge mindfulness meditation retreats do not last >8hours.
‡ Final sample composed of stage 0–I.
x Initial stages I–III planned.
jj Inclusion of patients with curative and palliative treatment—supposed 0–IV stages, unclear.
¶Without yoga (bone metastasis – poor performance status).
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Table 2
Participant adherence to MBIs.
Authors Year
Intervention dropout





Tacon et al[40] 2004 n/r n/r n/r n/r
Tacon et al[39] 2006 n/r n/r n/r n/r
Witek et al[23] 2008 6 4: n=1
5–6: n=12
7–8: n=31
All day retreat: n=31
n/r n/r
Matousek et al[24] 2010 4 Mean: 8.2
∗
(±1.1) 91.9† n/r






26.3 Median: 17 min/day‡
Matchim et al[26] 2011 4 Mean 6.3; range (4–8)
Retreat: n=9
78.9† n=7/15 completed 51%-71% of all HP
n=5/15 completed<50% of all HP
n=3/15 completed 71%–100% of all HP
Tacon et al[27] 2011 0 8: n=65 100 n/r
Henderson et al[18] 2012 n/r n/r n/r n/r













68.1 Yoga: mean 7 min/day
Meditation: mean 13 min/dayxx





Würtzen et al[41] 2013 31 n/r 81.5† n/r
Eyles et al[30] 2015 1 Mean: 8/9 range (6–9)
≥6 n=19—cut-offx
n/r n/r#
Johannsen et al[31] 2016 14 Mean 5/8 (±2.2) n/r Mean: 24 min/day
Bisseling et al[32] 2017 10 n/r 84.4† n/r




Kenne et al[20] 2017 2 n/r 97.0† n/r
Norouzi et al[34] 2017 n/r n/r n/r n/r
Pintado et al[21] 2017 n/r n/r n/r n/r
Vaziri et al[35] 2017 2 n/r 80† n/r
Zhang et al[36] 2017 1 n/r 96.7† n/r
Park et al[37] 2018 1 Mean: 7.7/8
≥7: n=12
n/r†† n/r




Zhang et al[42] 2019 4 n/r 88.6† n/r
Elimimian et al[38] 2020 n/r n/r n/r n/r
MBI = mindfulness-based intervention, n/r=not reported or unclear information.
∗
Among 9 classes (including retreat).
† Unclear whether all classes were completed or if some participants discontinued.
‡Median time: sitting 34min/week; walking 2min/week; body scan 19min/week; yoga 0min/week.
x The authors considered ICR when ≥6 classes were completed.
jj The authors considered ICR when ≥5 classes were completed.
¶ Among 8 classes (excluding retreat).
# The authors reported that home practice mean was of 27.40 min/day during the 8 weeks. However, it is unclear if home practice was estimated by adding classroom participation and home practice time, or only
home practice time.
∗∗
The authors considered ICR when ≥4 classes were completed.
†† No dropout, but discontinuation unclear: no participant missed >1 class.
‡‡ Cut-off of ≥6 classes is reported in Stafford et al (2015)[48] with the same sample.
xx Home practice was reported for 38 women among the 113 women assigned to the MBCR group.
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The average number of classes attended was 6 (range, 0–9), silent
retreat included, and the mean home practice duration was 25
min/day, 6days/week.[44] These results are comparable to those
of the face-to-face interventions reported in our review. Thus,
adaptations of the MBIs to different contexts and patients’ needs
should be further investigated. However, careful attention should
be paid to the description of how they are delivered, the
monitoring, and reporting of participant adherence and related
barriers. Our review shows that reports on the reasons for
dropping out from a study were lacking. These data are
important to learn which changes should be made to increase
participant adherence. Similarly, nearly half of the studies on
MBIs tested in various populations did not report data on
dropouts,[45] thus limiting the interpretation of implementability
of MBIs in specific settings.
To our knowledge, this review is the first to include qualitative
and quantitative data to determine participant adherence to
MBIs. However, although most of the studies provided some
information on participant adherence, inconsistencies in the
monitoring and reporting made comparison between the studies
difficult. These inconsistencies hampered data synthesis. Thus,
the exact amount of the participants’ engagement to improve
health outcomes still remains unclear.[43] The development of
guidelines structuring the reporting of MBI studies like those
existing for acupuncture interventions for example is recom-
mended.[46,47] If the above-mentioned limitations are addressed
in future studies, the preparation, interpretation, and comparison
of MBI studies might improve greatly.[12] A limitation of our
review is the screening of the articles that was done by the first
author only. Other relevant articles might have been missed or
excluded. Furthermore, only the data for 8-week MBIs were
included.
To conclude, about 70% of the studies reported some data on
participant adherence, revealing a relatively high overall
frequency of class attendance. However, the monitoring and
reporting of adherence should be improved in future studies. This
could increase our knowledge on the amount of participant
engagement needed to improve health outcomes and facilitate the
implementation of effective interventions on a larger scale.
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